Business Description

Description
Jaber Ebne Hayyan Pharmaceutical Co manufactures and markets injection and oral antibiotics, ointments, inhalers, nasal sprays, and pearls.
Name Current Vs Industry Vs History
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % 64.41
12-1 Month Momentum % 12.95

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 5.26
Forward Dividend Yield % 5.26
5-Year Yield-on-Cost % 5.26
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A

Financials

XTEH:DJBR1's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Jaber Ebne Hayyan Pharmaceutical Co Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil IRR)
EPS (TTM) (IRR) 0
Beta 0
Volatility % 94.95
14-Day RSI 0
14-Day ATR (IRR) 407.142857
20-Day SMA (IRR) 0
12-1 Month Momentum % 12.95
52-Week Range (IRR) 8220 - 18140
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Jaber Ebne Hayyan Pharmaceutical Co Filings

Filing Date Document Date Form
No Filing Data

Jaber Ebne Hayyan Pharmaceutical Co Stock Events

Financials Calendars
Event Date Price(IRR)
No Event Data

Jaber Ebne Hayyan Pharmaceutical Co Frequently Asked Questions

What is Jaber Ebne Hayyan Pharmaceutical Co(XTEH:DJBR1)'s stock price today?
The current price of XTEH:DJBR1 is IRR11220.00. The 52 week high of XTEH:DJBR1 is IRR18140.00 and 52 week low is IRR8220.00.
When is next earnings date of Jaber Ebne Hayyan Pharmaceutical Co(XTEH:DJBR1)?
The next earnings date of Jaber Ebne Hayyan Pharmaceutical Co(XTEH:DJBR1) is .
Does Jaber Ebne Hayyan Pharmaceutical Co(XTEH:DJBR1) pay dividends? If so, how much?
The  Dividend Yield %  of Jaber Ebne Hayyan Pharmaceutical Co(XTEH:DJBR1) is 5.26% (As of Today), Highest Dividend Payout Ratio of Jaber Ebne Hayyan Pharmaceutical Co(XTEH:DJBR1) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Jaber Ebne Hayyan Pharmaceutical Co(XTEH:DJBR1) is 5.26%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release